Cancer has become a disease characterized by its data. Insurance companies demand cost and utilization data, searching for a meaningful way to optimize value. Patients request test results, lab values, and physician notes, seeking to become shared decision-makers in their care. Researchers, pharmaceutical manufacturers, and others seek clinical data in an effort to further our biological understanding of the disease and provide clinicians with novel treatment compounds and decision support. Everyone wants cancer data, and yet the demand for quality oncology data far outstrips the provider community’s ability to collect and deliver such data. Read more here.